A Study to Evaluate the Safety and Pharmacokinetics of Ataluren in Participants From ≥6 Months to <2 Years of Age With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)
Clinical trial NCT04336826 · COMPLETED
Trial details
- NCT number
- NCT04336826
- Sponsor
- PTC Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-29
- Primary completion
- 2023-08-07
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.